FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
BMC Cancer
; 19(1): 351, 2019 Apr 11.
Article
in En
| MEDLINE
| ID: mdl-30975104
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Peptides
/
Neoplastic Stem Cells
/
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Immunophilins
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2019
Type:
Article
Affiliation country:
United kingdom